Your Article Summary
See Latest ArticlesThe Development of Primary Cutaneous Adenoid Cystic Carcinoma in a Patient with Ankylosing Spondylitis Treated with Etanercept
Southern Medical Journal, 06/30/09
Cansu DU et al. - The case of a patient with ankylosing spondylitis who developed cutaneous adenoid cystic carcinoma after three years of treatment with anti-TNF-[alpha] therapy is discussed.
Related Articles
Pretreatment With the Tumor Nerosis Factor-[alpha] Blocker Etanercept Attenuated Ischemia-Reperfusion Renal Injury
Transplantation Proceedings, 11/18/09
Relevance Score: 87%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 87%
Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis
Dermatology, 10/23/09
Relevance Score: 85%
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Cochrane Reviews, 10/12/09
Relevance Score: 84%
Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study
Zeitschrift für Rheumatologie, 10/07/09
Relevance Score: 84%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Journal of the National Cancer Institute, 12/14/09
A Holistic Approach to Androgen Deprivation Therapy: Treating the Cancer without Hurting the Patient
Urologia Internationalis, 12/14/09
Spontaneous reporting of adverse drug reactions at a department of Internal Medicine
Central European Journal of Medicine, 12/14/09